These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38390812)

  • 21. Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?
    Wächter S; Di Fazio P; Maurer E; Manoharan J; Keber C; Pfestroff A; Librizzi D; Bartsch DK; Luster M; Eilsberger F
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
    Naswa N; Sharma P; Suman Kc S; Lata S; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2012 Jul; 33(7):766-74. PubMed ID: 22531829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CT.
    Nazar AK; Kalshetty A; Chakravarty R; Chakraborty S; Basu S
    Nucl Med Commun; 2023 Oct; 44(10):910-923. PubMed ID: 37578310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
    Sasikumar A; Joy A; Nanabala R; Unni M; Tk P
    Clin Nucl Med; 2016 Dec; 41(12):e517-e519. PubMed ID: 27749421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT.
    Kuyumcu S; Has-Simsek D; Iliaz R; Sanli Y; Buyukkaya F; Akyuz F; Turkmen C
    Clin Nucl Med; 2019 Sep; 44(9):702-706. PubMed ID: 31348076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Performance of [
    Paymani Z; Rohringer T; Vali R; Loidl W; Alemohammad N; Geinitz H; Langsteger W; Beheshti M
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific Membrane Antigen Imaging in Recurrent Medullary Thyroid Cancer: A New Theranostic Tracer in the Offing?
    Arora S; Prabhu M; Damle NA; Bal C; Kumar P; Nalla H; Arun Raj ST
    Indian J Nucl Med; 2018; 33(3):261-263. PubMed ID: 29962733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
    Civan C; Isik EG; Simsek DH
    Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild
    Beyhan E; Erol Fenercioğlu Ö; Karagöz Y; Ergül N; Çermik TF
    Mol Imaging Radionucl Ther; 2022 Oct; 31(3):244-245. PubMed ID: 36268938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
    Verma P; Malhotra G; Agrawal R; Sonavane S; Meshram V; Asopa RV
    Clin Nucl Med; 2018 Aug; 43(8):e265-e268. PubMed ID: 29894335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of
    Tuncel M; Kılıçkap S; Süslü N
    Ann Nucl Med; 2020 Sep; 34(9):663-674. PubMed ID: 32602032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.
    Verma P; Malhotra G; Meshram V; Chandak A; Sonavane S; Lila AR; Bandgar TR; Asopa RV
    Clin Nucl Med; 2021 Aug; 46(8):e406-e409. PubMed ID: 33883490
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of
    Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
    Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
    Acar E; Kaya GÇ
    Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Arslan E; Aksoy T; Cin M; Çakır C; Can Trabulus FD; Çermik TF
    Mol Imaging Radionucl Ther; 2021 Feb; 30(1):63-66. PubMed ID: 33586413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent Medullary Thyroid Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT: Exploring New Theranostic Avenues.
    Arora S; Damle NA; Parida GK; Singhal A; Nalli H; Dattagupta S; Bal C
    Clin Nucl Med; 2018 May; 43(5):359-360. PubMed ID: 29485449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.